Results 51 to 60 of about 406 (135)
Consistent use injectable and oral chondroprotectors in patients with osteoarthritis and lower back pain. Case report [PDF]
Osteoarthritis (OA) is a disease of the entire joint, including structural changes in hyaline articular cartilage, subchondral bone, ligaments, capsule, synovial membrane and periarticular muscles.
Olga A. Shavlovskaya +2 more
doaj +1 more source
Ageing-related bone impairment due to exposure to hyperglycemic environment is scarcely researched. The aim was to confirm the improvement effects of undenatured type II collagen (UC II) on bone impairment in ageing db/db mice, and the ageing model was ...
Rui Fan +9 more
doaj +1 more source
In recent decades, there has been an increase in the prevalence and medical and social burden of osteoarthritis (OA) and nonspecific back pain in all countries of the world. The First Multidisciplinary Bilateral Russia-Uzbekistan Expert Council presented
Al. B. Danilov +34 more
doaj +1 more source
Piroxicam‐Collagen‐Based Sponges for Medical Applications
Depending on the concentration of the drug and/or the method of administration, drugs could be used in various ways. To take full advantage of the drug beneficial properties in oral medical interventions but also in other types of surgery, like plastic surgery, general surgery, or gynecological surgery, the drug concentration as well as the ...
Daniel-Cristian Ioan +7 more
wiley +1 more source
Pharmacotherapy of pain in musculoskeletal diseases: evolution and revolution of views
The article presents new views on the treatment of pain syndromes in musculoskeletal diseases, in particular in osteoarthritis (OA) of various localizations (gonarthrosis, coxarthrosis).
O. A. Shavlovskaya +6 more
doaj +1 more source
ABSTRACT Matrix protease activity is fundamental to developmental tissue patterning and remains influential in adult homeostasis. In cartilage, the principal matrix proteoglycan is aggrecan, the protease‐mediated catabolism of which defines arthritis; however, the pathophysiologic mechanisms that drive aberrant aggrecanolytic activity remain unclear ...
Clarissa R. Coveney +5 more
wiley +1 more source
Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
The review examines pharmacological agents that can have potential disease-modifying osteoarthritis drugs (DMOADs) status. DMOADs prevent the progression and further structural joint damage (structure-modifying effect), leading to a decrease in symptoms ...
O. A. Shavlovskaya +5 more
doaj +1 more source
Collagen has emerged as a potential pharmacotherapeutic intervention for knee osteoarthritis (OA). This study evaluates the effectiveness and safety of undenatured collagen type II among patients with knee OA and healthy subjects without joint-related ...
Cuiqing Chang, Yimin Zhao, Wei Liu
doaj +1 more source
ABSTRACT Packaging reduction, particularly in terms of single‐use plastic (SUP) packaging waste, as well as restrictions on specific packaging formats and regulatory requirements, are driving the demand for sustainable packaging solutions. Notably, within the category of SUP products, packaging accounts for the highest share at 40%. Therefore, advanced
Lokesh Kumar +3 more
wiley +1 more source
Diallyl trisulfides (DATs) selectively induce cuproptosis in hepatic stellate cells (HSCs) by targeting Ras‐related protein Rab‐18 (RAB18) and regulating lipophagy. DATs promote RAB18 phase separation, enhance mitochondrial‐associated membrane structures (MAMs) formation, and increase succinylation of dihydrolipoamide dehydrogenase (DLD) at K320.
Haoyuan Tian +16 more
wiley +1 more source

